Free Trial
→ This smart glasses tech is bringing the screen to your eyes (From The Tomorrow Investor) (Ad)tc pixel
NASDAQ:NBBK

NB Bancorp Q3 2026 Earnings Report

NB Bancorp logo
$22.48 +0.07 (+0.29%)
As of 10:56 AM Eastern
This is a fair market value price provided by Massive. Learn more.
ProfileEarnings HistoryForecast

NB Bancorp EPS Results

Actual EPS
N/A
Consensus EPS
$0.59
Beat/Miss
N/A
One Year Ago EPS
N/A

NB Bancorp Revenue Results

Actual Revenue
N/A
Expected Revenue
$77.30 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

NB Bancorp Announcement Details

Quarter
Q3 2026
Date
10/28/2026
Time
After Market Closes
Conference Call Date
Thursday, October 22, 2026
Conference Call Time
4:00PM ET

Conference Call Resources

NB Bancorp Earnings Headlines

IPO stock of the week: Regional banking leader NB Bancorp poised to hit new buy point
September 18, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/ipo-stock-of-the-week-regional-banking-leader-nb-bancorp-poised-to-hit-new-buy-point/ar-AA2cwcAD
KBRA Assigns Ratings to NB Bancorp, Inc.
September 16, 2026  |  finance.yahoo.comhttps://finance.yahoo.com/markets/stocks/articles/kbra-assigns-ratings-nb-bancorp-153800323.html
FDA Clears This Under-$5 Biotech for Phase 2 Clinical Trial
A NASDAQ-listed biotech just cleared a major regulatory milestone. The FDA has cleared its lead multiple sclerosis therapy, Lucid-MS, to enter Phase 2 clinical trials - the first time it will be tested in patients with progressive MS. Unlike treatments that suppress the immune system, Lucid-MS is designed to protect myelin, the insulating layer destroyed by the disease. In a pre-clinical mouse model, treatment led to movement recovery including walking. Independent research projects peak annual sales of up to $5 billion if Phase 2 succeeds. The stock still trades under $5 per share.tc pixel
October 6 at 1:00 AM  |  The Tomorrow Investor (Ad)
NBBK - NB Bancorp, Inc.
August 31, 2026  |  seekingalpha.comhttps://seekingalpha.com/symbol/NBBK/dividends/dividend-safety
Recent Quarterly Report Shows Improvement For NB Bancorp
August 1, 2026  |  seekingalpha.comhttps://seekingalpha.com/article/4929279-recent-quarterly-report-shows-improvement-for-nb-bancorp
IPO stock of the week: Regional banking leader NB Bancorp breaks out past buy point
August 1, 2026  |  msn.comhttps://www.msn.com/en-us/money/top-stocks/ipo-stock-of-the-week-regional-banking-leader-nb-bancorp-breaks-out-past-buy-point/ar-AA299Wxq
See More NB Bancorp Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NB Bancorp? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NB Bancorp and other key companies, straight to your email.

About NB Bancorp

NB Bancorp (NASDAQ:NBBK) is the bank holding company for Needham Bank, a community-oriented financial institution headquartered in Needham, Massachusetts. Through Needham Bank, the company provides banking and financial services to individuals, families, businesses, nonprofit organizations and municipalities.

Needham Bank offers deposit products, residential and commercial real estate lending, commercial and industrial loans, construction financing, consumer loans, cash-management services and other treasury-management solutions. The bank also provides wealth-management and investment-related services through its financial-services offerings.

Founded in 1892, Needham Bank serves customers primarily across Greater Boston, eastern Massachusetts and southern New Hampshire through its branch network and digital banking channels. NB Bancorp became the publicly traded holding company for Needham Bank following the bank’s mutual-to-stock conversion and initial public offering in 2024. Joseph Campanelli serves as president and chief executive officer of NB Bancorp and Needham Bank.

View NB Bancorp Profile
Earnings Tools